Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 35 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7323616

    Genetically altered mice deficient in functional caspase-9

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  2. US 7321063

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted
  3. US 7314885

    Pyrrole compounds useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted
  4. US 7312227

    Compositions useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2007 · Expires Dec 20, 2027

    granted
  5. US 7309716

    Benzimidazoles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted
  6. US 7304061

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  7. US 7304071

    Protein kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted
  8. US 7288624

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  9. US 7279469

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted
  10. US 7279476

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted
  11. US 7276502

    Thiazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted
  12. US 7273885

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted
  13. US 7271181

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted
  14. US 7271179

    Inhibitors of JAK protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted
  15. US 7268136

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2007 · Expires Sep 6, 2027

    granted
  16. US 7259161

    Compositions useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2007 · Expires Aug 16, 2027

    granted
  17. US 7256190

    Thiazole compounds useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted
  18. US 7253187

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted
  19. US 7250520

    Processes for preparing pyrroles

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2007 · Expires Jul 26, 2027

    granted
  20. US 7244735

    Heterocyclic protein kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted
  21. US 7241796

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2007 · Expires Jul 5, 2027

    granted
  22. US 7226920

    Aminotriazole compounds useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2007 · Expires May 31, 2027

    granted
  23. US 7216041

    Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2007 · Expires May 3, 2027

    granted
  24. US 7208600

    Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2007 · Expires Apr 19, 2027

    granted